Anti‐obesity and metabolic efficacy of the β3‐adrenergic agonist, CL316243, in mice at thermoneutrality compared to 22°C

Publisher： John Wiley & Sons Inc

E-ISSN： 1930-739x|23|7|1450-1459

ISSN： 1930-7381

Source： OBESITY, Vol.23, Iss.7, 2015-07, pp. : 1450-1459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The anti-obesity effects of a tuna peptide on 3T3-L1 adipocytes are mediated by the inhibition of the expression of lipogenic and adipogenic genes and by the activation of the Wnt/β-catenin signaling pathway

By          

International Journal of Molecular Medicine, Vol. 36, Iss. 2, 2015-01 ,pp. : 327-334

Spandidos Publications

Access to resources Recommend Favorite

A Combination of Glucosyl Hesperidin and Caffeine Exhibits an Anti‐obesity Effect by Inhibition of Hepatic Lipogenesis in Mice

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 2, 2015-02 ,pp. : 310-316

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soyasaponins Aa and Ab Exert an Anti‐Obesity Effect in 3T3‐L1 Adipocytes Through Downregulation of PPARγ

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 2, 2015-02 ,pp. : 281-287

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of the Selective β3‐Adrenoceptor Agonist Mirabegron in Japanese Patients with Overactive Bladder: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Study

By  

LUTS, Vol. 7, Iss. 2, 2015-05 ,pp. : 84-92

John Wiley & Sons Inc

Access to resources Recommend Favorite

Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a β3‐adrenoceptor agonist (Mirabegron) for overactive bladder (OAB)

By  

BJU INTERNATIONAL, Vol. 115, Iss. 1, 2015-01 ,pp. : 32-40

John Wiley & Sons Inc

Access to resources Recommend Favorite